Fang Taolin, Lineaweaver William C, Chen Michael B, Kisner Carson, Zhang Feng
Division of Plastic Surgery, University of Mississippi Medical Center, Jackson, Mississippi.
JMS Burn and Reconstructive Center, Crossgates River Oaks Hospital, Brandon, Mississippi.
J Reconstr Microsurg. 2014 Jan;30(1):1-13. doi: 10.1055/s-0033-1345429. Epub 2013 May 28.
Partial or complete necrosis of skin flaps remains a significant problem in plastic and reconstructive surgery. Growth factors have shown promise in improving flap survival through increased angiogenesis and blood supply to the flap. Vascular endothelial growth factor (VEGF) is the most widely investigated and successful one. But the mechanisms of the effects are still not very clear. In the course of a series of experiments, we indicated that tissue survival of surgical flaps could be improved by both preoperative (sustained phase effect) and intraoperative (acute phase effect) application of VEGF. We reviewed both experimental and clinical investigations on the use of VEGF with surgical flaps to summarize the evidence of both phases of VEGF activity in promotion of flaps survival in detail. With the combinations of acute and sustained phases of effects, VEGF protein and gene, VEGF morphologic actions, and VEGF histochemical modulations suggest a pattern of VEGF activity that can be superimposed on classic descriptive mechanisms of tissue survival of flaps.
